COMMUNIQUÉS West-GlobeNewswire

Madrigal Pharmaceuticals to Release Third-Quarter 2024 Financial Results and Host Webcast on October 31, 2024

18/10/2024 - 14:00

CONSHOHOCKEN, Pa., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) announced today that it will release its third-quarter 2024 financial results on Thursday, Oct. 31, 2024, prior to the [...]

Arcutis Announces Health Canada Approval of ZORYVE® (Roflumilast) Foam 0.3% to Treat Seborrheic Dermatitis in Individuals 9 Years of Age and Older

18/10/2024 - 14:20

ZORYVE foam represents the first topical treatment for seborrheic dermatitis with a new mechanism of action approved in Canada in over two decades 1 Second approval of ZORYVE outside of the United States, expanding [...]

Vivos Inc. Certifies New Clinic for IsoPet® Precision Radionuclide TherapyTM

18/10/2024 - 14:30

Richland WA N, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc. Certifies new clinic for IsoPet therapy. NorthStar Vets - Veterinary Emergency & Trauma Specialty Center in Robbinsville, NJ. [...]

SeaStar Medical Announces that Enrollment in its Adult Acute Kidney Injury Pivotal Trial Has Exceeded the Halfway Point Toward an Interim Analysis

18/10/2024 - 14:30

The pace of patient enrollment has significantly accelerated following a summertime slowdown DENVER, Oct. 18, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device [...]

FibroBiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based Therapies for Chronic Diseases

18/10/2024 - 14:30

HOUSTON, Oct. 18, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc., (Nasdaq: FBLG) (“FibroBiologics”) and Charles River Laboratories (“Charles River”), a leading global drug discovery, development, testing, and [...]

Oragenics, Inc. to Present at The Centurion One Capital 2nd Annual Bahamas Summit

18/10/2024 - 14:30

SARASOTA, Fla., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Oragenics Inc. (NYSE American: OGEN), a company focused on developing new treatments for brain-related health conditions, announced it will be presenting at the [...]

Jean Health Announces Expansion into Australia: Solving Urgent Rural Maternity Care Needs

18/10/2024 - 14:39

Jean Health has announced its expansion into Australia to address the urgent maternity care needs in rural areas. The company aims to improve maternal health outcomes through its AI-driven platform, create jobs, and [...]

Significant Positive Results from Osteoarthritis Clinical Study in Dogs Treated with Piclidenoson

18/10/2024 - 15:06

Data Reported by Can-Fite Veterinary Partner Vetbiolix who already exercised its option for a full license deal worth $325M Ramat Gan, Israel, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd . (NYSE American: [...]

Universal Health Care, LLC Opening a New Path in Healthcare

18/10/2024 - 15:35

DALLAS, Oct. 18, 2024 (GLOBE NEWSWIRE) -- via IBN -- Universal Care Groups LLC (“UCG”) is excited to announce that it is now offering a unique, platinum Section 125 Cafeteria plan (“125”) and a Minimum Essential [...]

ClinicPlast: Türkiye ranks in the top ten countries hosting patients from across the globe

18/10/2024 - 16:20

Ranking in the top ten countries hosting patients from across the globe, Türkiye’s health tourism sector was valued at USD 2.3 billion in 2023. With partnerships across leading healthcare and hospitality sectors, many [...]

Advanced Care Group Expands Nationwide with Acquisition of 3D Medical Staffing and AI-Powered Recruiting Solutions

18/10/2024 - 17:00

SALT LAKE CITY, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Advanced Care Group (AC Group) is proud to announce its nationwide expansion through the acquisition of 3D Medical Staffing. This strategic move strengthens our position [...]

RAMSAY SANTE : Résultats annuels au 30 juin 2024

18/10/2024 - 17:35

COMMUNIQUÉ DE PRESSE Paris, le 18 octobre 2024 Résultats annuels à fin juin 2024 Entreprise à mission, Ramsay Santé, grâce à ses collaborateurs et sa communauté médicale, s’engage à poursuivre et accélérer dans son rôle [...]

RAMSAY SANTE :Annual results at the end of June 2024

18/10/2024 - 17:35

PRESS RELEASE Paris, 18 th October 2024 Annual results at the end of June 2024 As a mission-driven company, Ramsay Santé, thanks to its employees and medical community, is committed to expanding its pioneering role in [...]

HeartFlow Announces New Category I CPT Code from the American Medical Association for AI-Enabled Plaque Analysis to Assess Risk for Coronary Artery Disease

18/10/2024 - 18:39

New reimbursement code follows recent favorable Medicare coverage decision, expanding access to HeartFlow’s Plaque Analysis to help physicians provide personalized treatment plans MOUNTAIN VIEW, Calif., Oct. 18, 2024 ( [...]

CVRx announces new CPT® Category I codes for Barostim

18/10/2024 - 20:08

MINNEAPOLIS, Oct. 18, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc . (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today that the American Medical Association (AMA) CPT® Editorial Panel has [...]

“A meaningful first step in acknowledging decades of harm”: Lung Health Foundation Applauds Landmark $32.5 Billion Legal Settlement Against Tobacco Companies

18/10/2024 - 20:10

TORONTO, Oct. 18, 2024 (GLOBE NEWSWIRE) -- The Lung Health Foundation (LHF), Canada’s premier resource on lung health research, education, and advocacy for all Canadians, is breathing a sigh of relief. On October 17, [...]

American Shared Hospital Services Announces Key Management Appointments

18/10/2024 - 20:58

Hires Gary Delanois, Seasoned Radiation Oncology Services Executive, as Chief Operating Officer Promotes Ranjit Pradhan to Senior Vice President of Sales and Marketing SAN FRANCISCO, Oct. 18, 2024 (GLOBE NEWSWIRE) -- [...]

XORTX Announces Closing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement

18/10/2024 - 22:00

CALGARY, Alberta, Oct. 18, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on developing [...]

Editas Medicine to Host Strategic Update Webinar to Detail Progress Towards 2024 Goals, Including Achievement of Establishing In Vivo Preclinical Proof of Concept

18/10/2024 - 22:01

Webinar to be held on Tuesday, October 22, at 8:00 a.m. ET CAMBRIDGE, Mass., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage gene editing company, today announced that it will [...]